(Q33235991)

24 July 2017

Novel peptide inhibitors of human kallikrein 2. (English)

1 reference

24 July 2017

Erkki Koivunen

6

0 references

Hannu Koistinen

object named as

Hannu Koistinen

4

0 references

Ulf-Håkan Stenman

8

object named as

Ulf-Håkan Stenman

1 reference

24 July 2017

Can Hekim

1

1 reference

24 July 2017

Jari Leinonen

2

1 reference

24 July 2017

Ale Närvänen

3

1 reference

24 July 2017

Lei Zhu

5

1 reference

24 July 2017

Ville Väisänen

7

1 reference

24 July 2017

language of work or name

English

0 references

publication date

9 March 2006

1 reference

Journal of Biological Chemistry

24 July 2017

1 reference

24 July 2017

281

1 reference

24 July 2017

18

1 reference

24 July 2017

12555-12560

1 reference

Results of conservative management of clinically localized prostate cancer.

24 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Immunopeptidometric assay for enzymatically active prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

An address system in the vasculature of normal tissues and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Selective alkylation and acylation of alpha and epsilon amino groups with PEG in a somatostatin analogue: tailored chemistry for optimized bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Tumor targeting with a selective gelatinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Peptides in cell adhesion research

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Antiangiogenic activity of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600014200

21 January 2018

Identifiers

DOI

10.1074/JBC.M600014200

1 reference

24 July 2017

1 reference